Drugmaker Dendreon files for Chapter 11 bankruptcy protection - Minn...
11/10/14
![]()
Drugmaker Dendreon files for Chapter 11 bankruptcy protection
Minneapolis Star Tribune
Prostate cancer drug developer Dendreon is seeking Chapter 11 bankruptcy protection with a plan that leads to either a sale of the company or a takeover by its lenders. The Seattle company listed more than $664 million in total debts and $364.6 million ...
[more]
Minneapolis Star Tribune
Prostate cancer drug developer Dendreon is seeking Chapter 11 bankruptcy protection with a plan that leads to either a sale of the company or a takeover by its lenders. The Seattle company listed more than $664 million in total debts and $364.6 million ...
- Feeds Categories: